Overview: Toxoplasma IgG Avidity TestIntroduction: The Toxoplasma IgG Avidity Test measures toxoplasma IgG avidity to determine recent or past infection. Following 2023 CDC guidelines, it uses immunoassays for high specificity, supporting infection screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in immunology, especially in pregnant women.
Other Names: Toxoplasma Avidity Assay, IgG Avidity Test.
FDA Status: Laboratory-developed test (LDT), meeting immunology standards for diagnostic accuracy.
Historical Milestone: Toxoplasma avidity testing began in the 1990s with congenital infection research. Immunoassay methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures toxoplasma IgG avidity to distinguish recent from past infection, guides treatment, and evaluates congenital risk.
Test Parameters: 1. Toxoplasma IgG Avidity
Pretest Condition: No fasting required. Collect serum or saliva. Report history of toxoplasmosis exposure or pregnancy.
Specimen: Serum (SST, 2-5 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document toxoplasmosis exposure, pregnancy, or immunocompromised status. Include current medications, especially antiparasitics.
Consent: Written consent required, detailing the tests purpose, congenital infection implications, and risks of sample collection.
Procedural Considerations: Uses enzyme-linked immunosorbent assay (ELISA) to measure toxoplasma IgG avidity. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for congenital risk assessment.
Factors Affecting Result Accuracy: Sample hemolysis or improper storage can affect results. Low IgG levels may reduce avidity accuracy.
Clinical Significance: High avidity confirms past infection, reducing congenital risk concerns. Low avidity suggests recent infection, guiding further testing or treatment.
Specialist Consultation: Consult an infectious disease specialist or obstetrician for result interpretation and treatment planning.
Additional Supporting Tests: Toxoplasma IgM, PCR, or IgG testing to confirm infection status.
Test Limitations: Non-specific in low IgG scenarios; clinical correlation is needed. Sample quality affects sensitivity.
References: CDC Toxoplasmosis Guidelines, 2023; Clinical Infectious Diseases, Liesenfeld O, 2022.
